FDA issued a Warning Letter to Noven Pharmaceuticals, Inc. on 8/5/2016 for a previous inspection.
483 Noven Pharmaceuticals Jan 2018

483 Noven Pharmaceuticals Jan 2018

Noreen Muniz FDA, Caroline Strasinger FDA$119.00 - Available Now

FDA investigators audited the Noven Pharmaceuticals - Miami, FL, United States facility and issued inspectional observations (via FDA 483) on 26 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Jan 2018
  • Location: Miami, United States
  • FEI: 1000222037
Add To Cart